Patents Assigned to Prophylix Pharma AS
  • Preparation useful for, and method for treatment of neonatal alloimmune thrombocytopenia (NAIT)
    Patent number: 9834613
    Abstract: A preparation useful for, and a method for the prophylactic treatment of women post-childbirth in order to avoid immunization and antibody production, which could induce NAIT and fetal/neonatal bleeding in subsequent pregnancies comprising administering a preparation containing antibodies to HPA 1a within 72 hours after delivery in the first non-compatible pregnancy.
    Type: Grant
    Filed: April 1, 2016
    Date of Patent: December 5, 2017
    Assignee: PROPHYLIX PHARMA AS
    Inventors: Bjorn Skogen, Anne Husebekk, Mette Kjaer, Jens Kjeldsen-Kragh
  • PREPARATION USEFUL FOR, AND METHOD FOR TREATMENT OF NEONATAL ALLOIMMUNE THROMBOCYTOPENIA (NAIT)
    Publication number: 20160215062
    Abstract: A preparation useful for, and a method for the prophylactic treatment of women post-childbirth in order to avoid immunization and antibody production, which could induce NAIT and fetal/neonatal bleeding in subsequent pregnancies comprising administering a preparation containing antibodies to HPA 1a within 72 hours after delivery in the first non-compatible pregnancy.
    Type: Application
    Filed: April 1, 2016
    Publication date: July 28, 2016
    Applicant: PROPHYLIX PHARMA AS
    Inventors: Bjorn SKOGEN, Anne HUSEBEKK, Mette KJAER, Jens KJELDSEN-KRAGH
  • Preparation useful for, and method for treatment of neonatal alloimmune thrombocytopenia (NAIT)
    Patent number: 8840897
    Abstract: A preparation useful for, and a method for the prophylactic treatment of women post-childbirth in order to avoid immunization and antibody production, which could induce NAIT and fetal/neonatal bleeding in subsequent pregnancies comprising administering a preparation containing antibodies to HPA1a within 72 hours after delivery in the first non-compatible pregnancy.
    Type: Grant
    Filed: December 29, 2006
    Date of Patent: September 23, 2014
    Assignee: Prophylix Pharma AS
    Inventors: Bjorn Skogen, Anne Husse-Bekk, Mette Kjaer Killie, Jens Kjeldsen-Kragh